Basic Information
| LncRNA/CircRNA Name | SOX21-AS1 |
| Synonyms | NA |
| Region | GRCh38_13:94712716-94716246 |
| Ensemble | ENSG00000227640 |
| Refseq | NR_046514 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Cervical Cancer |
| ICD-0-3 | C53 |
| Methods | qPCR |
| Sample | CC tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | In this study, we first reported that SOX21-AS1 expression was significantly upregulated in both CC tissues and cell lines. |
| Pubmed ID | 30912129 |
| Year | 2019 |
| Title | Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. |
External Links
| Links for SOX21-AS1 | GenBank HGNC NONCODE |
| Links for Cervical Cancer | OMIM COSMIC |